ALSUntangled 44: curcumin.
Publication
, Journal Article
Bedlack, R; ALSUntangled Group
Published in: Amyotroph Lateral Scler Frontotemporal Degener
November 2018
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Amyotroph Lateral Scler Frontotemporal Degener
DOI
EISSN
2167-9223
Publication Date
November 2018
Volume
19
Issue
7-8
Start / End Page
623 / 629
Location
England
Related Subject Headings
- Humans
- Drug Evaluation, Preclinical
- Curcumin
- Clinical Trials as Topic
- Anti-Inflammatory Agents, Non-Steroidal
- Animals
- Amyotrophic Lateral Sclerosis
- 3209 Neurosciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Bedlack, R., & ALSUntangled Group. (2018). ALSUntangled 44: curcumin. Amyotroph Lateral Scler Frontotemporal Degener, 19(7–8), 623–629. https://doi.org/10.1080/21678421.2018.1440738
Bedlack, Richard, and ALSUntangled Group. “ALSUntangled 44: curcumin.” Amyotroph Lateral Scler Frontotemporal Degener 19, no. 7–8 (November 2018): 623–29. https://doi.org/10.1080/21678421.2018.1440738.
Bedlack R, ALSUntangled Group. ALSUntangled 44: curcumin. Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7–8):623–9.
Bedlack, Richard, and ALSUntangled Group. “ALSUntangled 44: curcumin.” Amyotroph Lateral Scler Frontotemporal Degener, vol. 19, no. 7–8, Nov. 2018, pp. 623–29. Pubmed, doi:10.1080/21678421.2018.1440738.
Bedlack R, ALSUntangled Group. ALSUntangled 44: curcumin. Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7–8):623–629.
Published In
Amyotroph Lateral Scler Frontotemporal Degener
DOI
EISSN
2167-9223
Publication Date
November 2018
Volume
19
Issue
7-8
Start / End Page
623 / 629
Location
England
Related Subject Headings
- Humans
- Drug Evaluation, Preclinical
- Curcumin
- Clinical Trials as Topic
- Anti-Inflammatory Agents, Non-Steroidal
- Animals
- Amyotrophic Lateral Sclerosis
- 3209 Neurosciences
- 1109 Neurosciences
- 1103 Clinical Sciences